Xalkori

Xalkori (Crizotinib) is an oral prescription medicine used to treat certain types of non-small cell lung cancer. It works by blocking specific proteins that help cancer cells grow. Always consult a healthcare professional for proper use and dosage.

Xalkori (Crizotinib) is primarily used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is also prescribed for anaplastic lymphoma kinase (ALK)-positive or ROS1-positive metastatic NSCLC. This medication helps slow the growth of cancer cells by targeting specific genetic changes. It may be used when other treatments have not been effective.

Xalkori (Crizotinib) works within the body to help control cancer progression by interfering with proteins that promote tumor growth. Patients may experience improved energy levels or reduced symptoms related to their condition. Individual responses vary, and effects are typically monitored by a healthcare provider.

Xalkori (Crizotinib) should be taken exactly as prescribed by a doctor. It may interact with other medications, so inform your healthcare provider about all drugs you are using. Regular medical check-ups are important to monitor its effects and adjust treatment as needed.

Xalkori (Crizotinib) can interact with certain medications, including strong CYP3A inhibitors or inducers, which may affect its effectiveness. Grapefruit products should be avoided while taking this medicine. Always discuss potential interactions with your doctor or pharmacist before starting or stopping any medication.